- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03769480
Investigation of the Relationship Between Pulmonary Function and Muscle Strength in Athletes With Disability
December 7, 2018 updated by: Bihter Aslanyurek, Ankara Yildirim Beyazıt University
To investigate the relationship between respiratory function and core muscles strength in athletes with disabilities and compare with healthy athletes.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The determination of parameters affecting the performance of high performance athletes that are effective in performance is very important to determine the physical performance potential.
The body is a kinetic chain and core muscles play an important role in this chain.
The relationship between the performance ability of the athletes and the relationship between the core muscles and performance abilities and respiratory function is extremely important.
Different functional classifications caused by different barriers (physical, mental or visual) in many paralympic branches affect physical training because it is directly related to the classification, performance and training adaptations of an athlete.
Determining the parameters that affect the respiratory function of paralympics is very important to develop a training program with strategies that can affect the physical performance of athletes and thus to achieve the desired results in training and competitions.
Therefore, the aim of this study was to investigate the relationship between respiratory muscle strength and core muscle strength in paralympic athletes (athletes with disability).
Study Type
Observational
Enrollment (Anticipated)
25
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey
- Bihter Akınoğlu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 45 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
The study group is Athletes with disabilities.
The control group is the same sport branches but healthy athletes without any disabilites
Description
Inclusion Criteria:
- Being professional athletes for at least three years.
Exclusion Criteria:
- Having any lumbar injuries in the last three months,
- Having systemic problems other than their disabilities(for athletes with disabilities),
- Having any disability related to vision and hearing,
- Acute or chronic respiratory infection,
- Spinal cord injury level up to the innervation of the abdominal muscles (for paraplegic athletes).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Study Group
Study Group=Athletes with Disability
|
Muscle strength evaluation and Respiratory function Tests
|
|
Control Group
Control Group=Healthy Athletes
|
Muscle strength evaluation and Respiratory function Tests
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
FVC (the rate of normal value by the spirometer device)
Time Frame: 2 days
|
Functional vital capacity: will evaluate by the rate of normal value by the spirometer device (Pony FX Cosmed device)
|
2 days
|
|
FEV1 ( the rate of normal value by the spirometer device)
Time Frame: 2 days
|
First second Forced Expiratory Volume:will evaluate by the rate of normal value by the spirometer device (Pony FX Cosmed device)
|
2 days
|
|
Muscle strength (Abdominal Flexor Muscle Strength: will evaluate as Newtonmeter (Nm) by isokinetic device)
Time Frame: 2 days
|
Abdominal Flexor Muscle Strength: will evaluate as Newtonmeter (Nm) by isokinetic device (IsoMed 2000, trunk attachment).
|
2 days
|
|
Muscle strength (Abdominal Exstansor Muscle Strength: will evaluate as Newtonmeter (Nm) by isokinetic device)
Time Frame: 2 days
|
Abdominal Extensor Muscle Strength: will evaluate as Newtonmeter (Nm) by isokinetic device (IsoMed 2000, trunk attachment).
|
2 days
|
|
Muscle strength (Abdominal right rotator Muscle Strength: will evaluate as Newtonmeter (Nm) by isokinetic device)
Time Frame: 2 days
|
Abdominal right rotator Muscle Strength: will evaluate as Newtonmeter (Nm) by isokinetic device (IsoMed 2000, trunk attachment).
|
2 days
|
|
Muscle strength (Abdominal left rotator Muscle Strength: will evaluate as Newtonmeter (Nm) by isokinetic device)
Time Frame: 2 days
|
Abdominal left rotator Muscle Strength: will evaluate as Newtonmeter (Nm) by isokinetic device (IsoMed 2000, trunk attachment).
|
2 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Tuğba Kocahan, Dr, The Ministry of Youth and Sports, Sports General Directorship, Ankara, Turkey
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2018
Primary Completion (Anticipated)
January 1, 2019
Study Completion (Anticipated)
February 1, 2019
Study Registration Dates
First Submitted
November 29, 2018
First Submitted That Met QC Criteria
December 6, 2018
First Posted (Actual)
December 7, 2018
Study Record Updates
Last Update Posted (Actual)
December 10, 2018
Last Update Submitted That Met QC Criteria
December 7, 2018
Last Verified
December 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- 2 (Other Identifier: Instituto Cardiovascular de Buenos Aires)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The participants all is national team.
Because we can not share the data
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Disabilities Multiple
-
Cairo UniversityCompletedDisabilities MultipleEgypt
-
Rush University Medical CenterUniversity of Minnesota; St. John Fisher CollegeRecruitingDisabilities MultipleUnited States
-
William EvansGeorgia Southern University; Health Association of Niagara County, Inc.; Catholic... and other collaboratorsRecruiting
-
University Hospital, BrestRecruitingStakeholder Perspectives on the Need for a Digital Solution in Pediatric Rehabilitation (ProChRehab)Children | Disability Physical | Disabilities Multiple | Disability, DevelopmentalFrance
-
University of Illinois at ChicagoNational Center for Advancing Translational Sciences (NCATS)RecruitingDisabilities MultipleUnited States
-
Maastricht University Medical CenterStichting Pergamijn (Gouverneur Kremers Centrum/azM); Koraalgroep(Gouverneur... and other collaboratorsUnknownMalnutrition | Complex Multiple DisabilitiesNetherlands
-
University Hospital, Clermont-FerrandNot yet recruitingDisabilities Multiple | Dental Phobia | Complex Medical Health ConditionFrance
-
Maharishi Markendeswar University (Deemed to be...Completed
-
University of Missouri-ColumbiaNational Institute on Aging (NIA)CompletedReducing COVID-19 Related Disability in Rural Community-Dwelling Older Adults Using Smart TechnologyQuality of Life | Disabilities MultipleUnited States
-
Groupe Hospitalier Mutualiste de GrenobleCompletedDisabilities Mental | Disabilities PhysicalFrance
Clinical Trials on Muscle strength evaluation and Respiratory function Tests
-
Westfälische Wilhelms-Universität MünsterUnknownRespiratory Muscle ParalysisGermany
-
Istanbul University - Cerrahpasa (IUC)RecruitingPediatric-onset Multiple SclerosisTurkey
-
Çankırı Karatekin UniversityRecruitingBipolar Disorder (BD) | Schizophenia DisorderTurkey (Türkiye)
-
Bezmialem Vakif UniversityCompletedCystic Fibrosis | Primary Ciliary DyskinesiaTurkey
-
Centre d'Investigation Clinique et Technologique...Unknown
-
Hacettepe UniversityRecruitingCongenital Heart Disease | Fontan ProcedureTurkey
-
Gazi UniversityT.C. Dumlupınar ÜniversitesiCompletedRespiratory Muscles and Core StabilizationTurkey
-
Biruni UniversityAtlas UniversityCompletedChronic Obstructive Pulmonary DiseaseTurkey
-
University of FloridaCompleted
-
Rigshospitalet, DenmarkMerck Sharp & Dohme LLC; Roche Pharma AG; Beckett Foundation; Onkologisk ForskningsfondUnknownUrinary Bladder NeoplasmDenmark